Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond C Stevens

Showing results (21-30 of 330) with videos related to

Pageof 33
Sort By:
Trends in Pharmacological Sciences|October 29, 2011
Diversity and modularity of G protein-coupled receptor structuresVsevolod Katritch, Vadim Cherezov, Raymond C Stevens
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2008
Protein crystallization in restricted geometry: advancing old ideas for modern times in structural proteomicsJoseph D Ng, Raymond C Stevens, Peter Kuhn
Cell|July 29, 2017
How Ligands Illuminate GPCR Molecular PharmacologyDaniel Wacker, Raymond C Stevens, Bryan L Roth
Angewandte Chemie (International Ed. in English)|November 8, 2015
In-Membrane Chemical Modification (IMCM) for Site-Specific Chromophore Labeling of GPCRsLukas Sušac, Casey O'Connor, Raymond C Stevens, et al.
Structure (London, England : 1993)|July 29, 2014
Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challengesIrina Kufareva, Vsevolod Katritch, , et al.
Angewandte Chemie (International Ed. in English)|October 26, 2012
β2-Adrenergic receptor solutions for structural biology analyzed with microscale NMR diffusion measurementsReto Horst, Pawel Stanczak, Raymond C Stevens, et al.
Journal of Molecular Biology|January 29, 2008
Stabilization of the human beta2-adrenergic receptor TM4-TM3-TM5 helix interface by mutagenesis of Glu122(3.41), a critical residue in GPCR structureChristopher B Roth, Michael A Hanson, Raymond C Stevens
FEBS Letters|June 5, 2004
Structural commonalities among integral membrane enzymesMichael H Bracey, Benjamin F Cravatt, Raymond C Stevens
Current Opinion in Chemical Biology|November 5, 2002
The genesis of high-throughput structure-based drug discovery using protein crystallographyPeter Kuhn, Keith Wilson, Marianne G Patch, et al.
Biochemistry|March 8, 2006
Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificityJoseph W Arndt, Qing Chai, Todd Christian, et al.
Pageof 33

Showing results (21-30 of 330) with videos related to

Sort By:
Pageof 33
Trends in Pharmacological Sciences|October 29, 2011
Diversity and modularity of G protein-coupled receptor structuresVsevolod Katritch, Vadim Cherezov, Raymond C Stevens
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2008
Protein crystallization in restricted geometry: advancing old ideas for modern times in structural proteomicsJoseph D Ng, Raymond C Stevens, Peter Kuhn
Cell|July 29, 2017
How Ligands Illuminate GPCR Molecular PharmacologyDaniel Wacker, Raymond C Stevens, Bryan L Roth
Angewandte Chemie (International Ed. in English)|November 8, 2015
In-Membrane Chemical Modification (IMCM) for Site-Specific Chromophore Labeling of GPCRsLukas Sušac, Casey O'Connor, Raymond C Stevens, et al.
Structure (London, England : 1993)|July 29, 2014
Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challengesIrina Kufareva, Vsevolod Katritch, , et al.
Angewandte Chemie (International Ed. in English)|October 26, 2012
β2-Adrenergic receptor solutions for structural biology analyzed with microscale NMR diffusion measurementsReto Horst, Pawel Stanczak, Raymond C Stevens, et al.
Journal of Molecular Biology|January 29, 2008
Stabilization of the human beta2-adrenergic receptor TM4-TM3-TM5 helix interface by mutagenesis of Glu122(3.41), a critical residue in GPCR structureChristopher B Roth, Michael A Hanson, Raymond C Stevens
FEBS Letters|June 5, 2004
Structural commonalities among integral membrane enzymesMichael H Bracey, Benjamin F Cravatt, Raymond C Stevens
Current Opinion in Chemical Biology|November 5, 2002
The genesis of high-throughput structure-based drug discovery using protein crystallographyPeter Kuhn, Keith Wilson, Marianne G Patch, et al.
Biochemistry|March 8, 2006
Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificityJoseph W Arndt, Qing Chai, Todd Christian, et al.
Pageof 33